Refine Search
(17)
(33)
(95)
(96)

Marburg Hemorrhagic Fever - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Marburg Hemorrhagic Fever - Pipeline Review, H2 2016’, provides an overview of the Marburg Hemorrhagic Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Helicobacter pylori Infections - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Helicobacter pylori Infections - Pipeline Review, H2 2016’, provides an overview of the Helicobacter pylori Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Neisseria gonorrhoeae Infections - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neisseria gonorrhoeae Infections - Pipeline Review, H2 2016’, provides an overview of the Neisseria gonorrhoeae Infections pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Influenza B Infections - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Influenza B Infections - Pipeline Review, H2 2016’, provides an overview of the Influenza B Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Epstein-Barr Viral Infections - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Epstein-Barr Viral Infections - Pipeline Review, H2 2016’, provides an overview of the Epstein-Barr Viral Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Coronaviridae Infections - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Coronaviridae Infections - Pipeline Review, H2 2016’, provides an overview of the Coronaviridae Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Poxviridae Infections - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Poxviridae Infections - Pipeline Review, H2 2016’, provides an overview of the Poxviridae Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Po...

Varicella Zoster (HHV-3) Infections - Pipeline Review, H2 2016

  • $2,000
  • September 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Varicella Zoster (HHV-3) Infections - Pipeline Review, H2 2016’, provides an overview of the Varicella Zoster (HHV-3) Infections pipeline landscape.

The report provides comprehensive information on the therapeut...

Equine Encephalitis - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Equine Encephalitis - Pipeline Review, H2 2016’, provides an overview of the Equine Encephalitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Equine...

Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2016’, provides an overview of the Genital Warts (Condylomata Acuminata) pipeline landscape.

The report provides comprehensive information on the thera...

Dermatomycoses - Pipeline Review, H2 2016

  • $2,000
  • November 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dermatomycoses - Pipeline Review, H2 2016’, provides an overview of the Dermatomycoses pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dermatomycoses, ...

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections - Pipeline Review, H2 2016’, provides an overview of the Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infe...

Streptococcal Pneumonia - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Streptococcal Pneumonia - Pipeline Review, H2 2016’, provides an overview of the Streptococcal Pneumonia pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Bacterial Pneumonia - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bacterial Pneumonia - Pipeline Review, H2 2016’, provides an overview of the Bacterial Pneumonia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bacter...

Burkholderia Infections - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Burkholderia Infections - Pipeline Review, H2 2016’, provides an overview of the Burkholderia Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...